Wednesday, September 27, 2000

07.30–08.30

BREAKFAST BUFFET

V. Mastocytosis:

08.30–9.10

c-Kit mutations in mastocytosis
F.FEGER, Paris, France

09.10–09.50

Tryptase in mastocytosis
D.LUDOLPH-HAUSER, Munich.

09.50–10.20

COFFEE BREAK

10.20–11.00

Cytogenetic alterations in systemic mastocytosis
M.LISHNER, Israel

11.00–11.40

Indolinone derivatives inhibit constitutively activated kit mutants and kill neoplastic tumor cells
B.J.LONGLEY, New York, USA

11.40–12.20

Mastocytosis cells bearing a c-kit activation mutation are characterized by hypersensitivity to stem cell factor and increased programmed cell death
Y.DROR, Toronto, Canada

12.20-14.00

LUNCH BUFFET

VI. Familial eosinophilia and the acquired idiopathic eosinophilic syndrome (IHS):

14.00–14.40

Familial eosinophilia
A. KLION, Bethesda, MD, USA

14.40–15.20

Wilms tumor gene Expression in IHS
H.D.MENSSEN, Berlin, Germany

15.20–15.50

COFFEE BREAK

15.50–16.30

Clonality of eosinophils in IHS
Szu-Hee LEE, Singapore

16.30–17.10

Clonal lymphocytes in patients with IHS
F.ROUFOSSE, Brussels


VII. From bench to bedside:

17.10-17.50

Development of drugs for orphan diseases
N.N.

17.50-18.00 Concluding remarks:
Petro E. PETRIDES and Heike L.PAHL
18.00- POSTER VIEWING AND SOCIAL HOUR
  Farewell DINNER

 

14.08.2000 22:12